Chikujee
Therapeutics is an integrated
biopharmaceutical company that
applies its innovative drug
development & commercialization
Platform to generate a pipeline of
personalized medicine products to
detect, treat and monitor cancer.
Chikujee’s Aayush platform includes
a complementary portfolio of
personalized diagnostics, targeted
therapeutics and reporters of
efficacy to create novel
disease-specific personalized
medicine products. The approach
takes the product development a step
further that the current combination
products (different but packaged
together diagnostics and
therapeutics), by integrating them
in one integrated product with
diagnostic, therapeutic and
monitoring capabilities.
Chikujee Therapeutics is a privately owned company. To inquire about investment opportunities, please contact
investor.relations@Chikujee.com.
